Volume 93, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Confusion between salt/base forms of primaquine may result in malaria prophylaxis failure. During 1995–2011, there were 14 malaria cases in Israel despite primaquine primary prophylaxis. In 6/14 cases, primaquine was underdosed because of confusion between salt and base forms, including two cases. Primaquine labeling clarification may be lifesaving.


Article metrics loading...

Loading full text...

Full text loading...



  1. Schlitzer M, , 2007. Malaria chemotherapeutics part I: history of antimalarial drug development, currently used therapeutics, and drugs in clinical development. Chem Med Chem 2: 944986.[Crossref]
  2. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ, , 2006. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg 75: 402415.
  3. Kathrine RT, Paul MA, Stefanie FS, , 2014. Infectious diseases related to travel: malaria. CDC Health Information for International Travel 2014. Centers for Disease Control and Prevention (CDC). Available at: http://wwwnc.cdc.gov/travel/page/yellowbook-home-2014. Accessed February 4, 2015.
  4. U.S. Pharmacopeial Convention (USP). Monograph Naming Policy for Salt Drug Substances in Drug Products and Compounded Preparations. Available at: http://www.usp.org/sites/default/files/usp_pdf/EN/2014-12-01_nom_guidelines.pdf. Last revision on: December 1, 2014.
  5. Schwartz E, Schwartz E, , 2009. Malaria in travelers: epidemiology, clinical aspects and treatment. , ed. Tropical Diseases in Travelers. New York, NY: John Wiley and Sons.[Crossref]
  6. State of Israel Ministry of Health, 2013. Guidelines for Persons Travelling Overseas, 2013 Update, Epidemiology Division, Public Health Services (Hebrew). Available at: http://www.health.gov.il/Subjects/vaccines/Vaccines_abroad/Documents/travel2013.pdf. Accessed December 10, 2013.
  7. Thomsen LA, Winterstein AG, Sondergaard B, Haugbolle LS, Melander A, , 2007. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 41: 14111426.[Crossref]
  8. Latif A, Rawat N, Pustavoitau A, Pronovost PJ, Pham JC, , 2013. National study on the distribution, causes, and consequences of voluntarily reported medication errors between the ICU and non-ICU settings. Crit Care Med 41: 389398.[Crossref]
  9. Avery AJ, Ghaleb M, Barber N, Dean Franklin B, Armstrong SJ, Serumaga B, Dhillon S, Freyer A, Howard R, Talabi O, Mehta RL, , 2013. The prevalence and nature of prescribing and monitoring errors in English general practice: a retrospective case note review. Br J Gen Pract 63: e543e553.[Crossref]
  10. Singh K, Wester WC, Trenholme GM, , 2003. Problems in the therapy for imported malaria in the United States. Arch Intern Med 163: 20272030.[Crossref]
  11. Dorlo TP, Kager PA, , 2008. Pentamidine dosage: a base/salt confusion. PLoS Negl Trop Dis 2: e225.[Crossref]
  12. Schwartz E, Regev-Yochay G, Kurnik D, , 2000. Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria. Am J Trop Med Hyg 62: 393395.
  13. Shihmanter R, Nulman I, Goland S, Caspi A, Bar-Haim A, Harary I, Berkovitch M, Arcavi L, , 2014. Variation in the CYP2D6 genotype is not associated with carvedilol dose changes in patients with heart failure. J Clin Pharm Ther 39: 432438.[Crossref]

Data & Media loading...

  • Received : 19 Feb 2014
  • Accepted : 23 Feb 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error